-transparent.png){kind=logo}
The pathogenic role of the sympathetic system in essential hypertension was evaluated by combined analysis of plasma catecholamine levels and the pressor sensitivity to endogenous norepinephrine. The latter was estimated indirectly by the ratio between changes in blood pressure and those in plasma norepinephrine after adrenergic neuronal blockage with debrisoquine (given orally for 6 weeks). Normal subjects and patients with borderline or established essential hypertension had comparable pretreatment levels of plasma norepinephrine and epinephrine. Debrisoquine lowered plasma norepinephrine by a similar degree (almost 50%) in these three groups; in contrast, blood pressure decreased only slightly in normal or borderline hypertensive subjects [-3.4 +/- 3.2% and -5.4 +/- 1.6% (SE), respectively] but fell significantly more (P less than 0.005) in patients with established essential hypertension (-20.7 +/- 3.9%). The ratio between percentile changes in blood pressure and those in endogenous norepinephrine levels was comparable in normal and borderline hypertensive subjects (0.03 +/- 0.08 and 0.17 +/- 0.04, respectively), but increased (P less than 0.001) in established essential hypertension (0.62 +/- 0.11). This suggests that essential hypertension may be maintained, at least partly, by the inappropriate association of normal plasma norepinephrine levels with increased norepinephrine pressor sensitivity.
P Weidmann, and
G Keusch, and
J Flammer, and
W H Ziegler, and
F C Reubi
November 1987,
Japanese circulation journal,
P Weidmann, and
G Keusch, and
J Flammer, and
W H Ziegler, and
F C Reubi
July 1987,
The Korean journal of internal medicine,
P Weidmann, and
G Keusch, and
J Flammer, and
W H Ziegler, and
F C Reubi
January 1978,
Transactions of the Association of American Physicians,
P Weidmann, and
G Keusch, and
J Flammer, and
W H Ziegler, and
F C Reubi
January 1996,
Contributions to nephrology,
P Weidmann, and
G Keusch, and
J Flammer, and
W H Ziegler, and
F C Reubi
April 2001,
American journal of hypertension,
P Weidmann, and
G Keusch, and
J Flammer, and
W H Ziegler, and
F C Reubi
January 1983,
Cardiology,
P Weidmann, and
G Keusch, and
J Flammer, and
W H Ziegler, and
F C Reubi
October 1989,
American heart journal,
P Weidmann, and
G Keusch, and
J Flammer, and
W H Ziegler, and
F C Reubi
March 1973,
The New England journal of medicine,
P Weidmann, and
G Keusch, and
J Flammer, and
W H Ziegler, and
F C Reubi
April 1991,
Hypertension (Dallas, Tex. : 1979),
P Weidmann, and
G Keusch, and
J Flammer, and
W H Ziegler, and
F C Reubi
January 1982,
Clinical and experimental hypertension. Part A, Theory and practice,
